摘要
The present study investigated a combination of prostate cancer-targeting doxorubicin (DOX) nanomicelles with photother-mal therapy of castration-resistant prostate cancer (CRPC) in vitro and in vivo. Nanomicelles formed by the self-assembly of superparamagnetic ferrite, polyethyleneimine, and polyethylene glycol were used as the carriers, and the chemotherapy drug DOX was embedded in the nanomicelles. The photothermal properties of the nanomicelles and the toxic effects of prostate cancer-targeting nanomicelles were evaluated. The therapeutic effects in the BP@PGE, BP@PGE + NIR, BP@PGE-dox, and BP@PGE-dox+NIR groups were compared. Prostate cancer-targeting DOX nanomicelles were suc-cessfully formed. The drug release was stable, and the cytotoxicity and blood compatibility tests demonstrated that the prostate cancer-targeting DOX nanomicelles were safe for normal cells. The temperature of BP@PEG was increased to 52 & DEG;C upon a laser irradiation of 808 nm at a power density of 1.5 W/cm2; however, the temperature of BP-DOX was IP: 2038 10920 On: Thu 22 Sep 2022 09:44:53 increased to 48 & DEG;C within 5 min. DOX loading did not influence thphotothermal performance of the nanomaterials. The Copyright American Scientific Publishers in vitro and in vivo studies showed that the prostate cancer-targeting DOX nanomicelles combined with photothermal Delivered by Ingenta therapy were an effective treatment for CRPC. Prostate cancer-targeting DOX nanomicelles had no systemic toxicity to the organism and ensured safe biological application of these agents.
-
单位南方医科大学; y